Summary
A toxicology study was performed in mice given a superpotent α melanocyte stimulating hormone (MSH) analog. This 13 amino acid derivative, [Nle4, D-Phe7]α-MSH or NDP-MSH, is a melanotropin which is very slowly biodegraded in vivo and is active at 1/1,000 the concentration of natural α-MSH. Mice were administered up to 2 mg/kg of the analog daily and weekly over 4 or 12 weeks by both topical application (in 90% DMSO) or by IP injections (in physiologic saline). At the end of this period, no toxic effects were observed in various organs, on hematologic indices, or on weight gain. A slight increase in triglyceride and platelet levels were noted in mice given the analog weekly for 12 weeks. There was no evidence of an effect on behavior nor ACTH-like endocrine actions such as elevated serum cortisol levels. Transdermal drug delivery studies performed in vitro showed reproducible diffusion of the NDP-MSH analog through full-thickness mouse skin. Approximately 0.002% to 0.05% of a 10−4M preparation was transdermally delivered using a DMSO/water solution or a PEG/alcohol cream base, respectively. This superpotent analog is now entering a Phase I clinical trial with possible therapeutic applications for the treatment of hypomelanotic disorders such as vitiligo and for pharmacologic tanning without the need for sunlight exposure.
Similar content being viewed by others
References
Hadley ME: Endocrinology, Prentice-Hall Inc., Englewood Cliffs, N.J. 1984, pp. 160–181
Fitzpatrick TB, Hori K, Seiji M: Jap J Dermatol 79:278–281, 1969
Li CH: The chemistry of melanotropin. In: Hormonal Protein and Peptides, CH Li (ed) Academic New York Press, Inc. 1978, pp. 1–33
Schreiber MM, Shapiro SL, Berry CZ: The incidence of skin cancer in southern Arizona. Arch Dermatol 104:124–127, 1971
Sawyer TK, Sanfilippo PJ, Hruby VJ, Engel MH, Heward CB, Burnett B, Hadley ME: [Nle4, D-Phe7]-α-M 1 nocyte stimulating hormone: A highly potent α-melanotropin with ultralong biological activity. Proc Natl Acad Sci U.S.A. 77:5754–5758, 1980
Sawyer TK, Hruby VJ, Wilkes BT, Draelos MT, Hadley ME, Bergschneider M: Design and comparative biological activities of highly potent analogs of α-melanotropins. J Med Chem 25:1022–1027, 1982
Hadley ME, Mieyr JH, Martin BE, Upton JL, Castrucci AML, Hruby VJ, Power EA, Rango Rao K: [Nle4, D-Phe7]-α-MSH: A superpotent melanotropin with prolonged action on vertebrate chromatophores. Comp Biochem Physiol 81A:1–16, 1985
Hadley ME, Anderson B, Howard CB, Sawyer TK, Hruby VJ: Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-α-melanotropin. Science 213:1025–1027, 1981
Freireich JEJ, Gehan EA, Rall DP, Schmidt LH, Skiper HE: Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 50:219–244, 1966
Shizume K, Lerner AB, Fitzpatrick TB: In vitro bioassay for the melanocyte stimulating hormone. Endocrinology 54:553–560, 1954
Kreutzfeld KL, Wilson ST, Bagnara JT: Specificity of an α-MSH, radioimmunoassay for [Nle4-D-Phe7]-α-MSH, a superpotent α-melanotropin. J Invest Derm (Abstract) 87(3):416, 1986
Ames BN, Durston WE, Yamasaki E, Lee FD: Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U.S.A. 70:2281–2285, 1973
Lipton JM: MSH in CNS control of fever and its influence on inflammation/immune response. In: The Melanotropic Peptide, (Lipton, ed), CRC Press, Boca Raton (In Press, 1988)
Holdeman M, Lipton JM: Antipyretic activity of a potent α-MSH analog. Peptides 6:273–277, 1985
Geshwind II, Huseby RA, Nishioka R: The effect of melanocyte stimulating hormone on coat color in the mouse. Rec Prog Horm Res 28:91–130, 1972
Hadley ME, Wood SH, Jessen GL, Lemus-Wilson AL, Dawson BV, Levine N, Dorr RT, Hruby VJ: Topical application of a melanotropic peptide induces systemic follicular melanogenesis. Life Sci 40:1889–1895, 1987
Maibach HI, Stoughton RB: Topical corticosteroids. Med Clin No Amer 57(5): 1253–1269, 1973
Bregman MD, Abdel-Malek ZA, Meyskens FL, Jr: Anchorage-independent growth of murine melanoma in serum-less media is dependent on insulin or melanocyte-stimulating hormone. Exper Cell Res 157:419–428, 1985
Halaban R, Lerner AB: The dual effect of melanocyte-stimulating hormone (MSH) on the growth of cultured mouse melanoma cells. Exper Cell Res 108:111–117, 1977
Abdel-Malek ZA, Hadley ME, Bregman MD, Meyskens FL, Jr, Hruby VJ: Actions of melanotropins on mouse melanoma cell growth in vitro. J Natl Cancer Inst 76:857–863, 1986
Abdel-Malek ZA, Kreutzfeld KL, Hadley ME, Bregman MD, Hruby VJ, Meyskens FL: Melanotropin stimulation of S91 melanoma cell tyrosinase activity is density dependent. In Vitro 22:75–81, 1986
Lerner AB: On the Etiology of Vitiligo and Gray Hair. Amer J Med 51(2):141–147, 1971
Warren R: Pigmentation induction by melanocyte stimulating hormone in human skin culture. (Abstr) Clin Res 35:723A, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dorr, R.T., Dawson, B.V., Al-Obeidi, F. et al. Toxicologic studies of a superpotent α-melanotropin, [Nle4, D-Phe7]α-MSH. Invest New Drugs 6, 251–258 (1988). https://doi.org/10.1007/BF00173642
Issue Date:
DOI: https://doi.org/10.1007/BF00173642